Submission Details
| 510(k) Number | K130082 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 14, 2013 |
| Decision Date | December 20, 2013 |
| Days to Decision | 340 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K130082 is an FDA 510(k) clearance for the GENPRIME DRUGS OF ABUSE READER SYSTEM, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by Genprime, Inc. (Oms River, US). The FDA issued a Cleared decision on December 20, 2013, 340 days after receiving the submission on January 14, 2013. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K130082 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 14, 2013 |
| Decision Date | December 20, 2013 |
| Days to Decision | 340 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |